Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes
about
The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studiesNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.miR-Let7A Controls the Cell Death and Tight Junction Density of Brain Endothelial Cells under High Glucose Condition.Targeting Cognitive Impairment in Multiple Sclerosis-The Road toward an Imaging-based BiomarkerIncreased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mappingCerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.MR imaging in multiple sclerosis: review and recommendations for current practice.Nanomaterial applications in multiple sclerosis inflamed brain.Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities.Quantification of blood-to-brain transfer rate in multiple sclerosis.Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.Validating Nonlinear Registration to Improve Subtraction Images for Lesion Detection and Quantification in Multiple Sclerosis.Lesion enhancement diminishes with time in primary progressive multiple sclerosis.Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.Studying the blood-brain barrier will provide new insights into neurodegeneration - Yes.Advances in the molecular imaging of multiple sclerosis
P2860
Q24605294-0C2C0B3E-80FA-4FA0-8331-940E144C49DAQ30576477-602956CF-7466-403F-ABB1-81216093B32BQ30977551-2713A6B1-1C3F-4B63-A10F-6B1D32B619FAQ33770621-76CBDA87-504E-41D5-A56D-89D137F315A2Q33819951-59BAC1EF-2E7A-492B-8145-A6509359497BQ33855765-30EA63D9-1486-47A2-B9EA-033A6F02FCC8Q35182294-B4284A3E-4EC0-442E-A459-05E6B248D9CBQ35720710-37ABC0C6-E89F-4F3C-9C2A-22327FEF881FQ35937975-2EAAEC79-7111-40DD-A918-74A2A1FE7B58Q36659375-51EED694-D32F-429A-8E01-A4ABC1F1EEA6Q37108898-638F4F3F-7695-4A8A-834A-ADCD47A778DEQ37459845-791EE675-E157-4D78-8D81-D2EDE07DC532Q37658010-200D1A3C-4B6D-407A-B12D-AB54A731AF58Q38330408-35A8306F-5C8A-4E8C-A510-11FF37B14B50Q39729727-CA505DE2-4703-4F7B-8DD0-193463C2DACFQ41068167-38402C12-12E1-4268-8064-60FA88B7ECF0Q42433959-5F95FEC1-608A-4772-B48C-28463160B6CBQ45051419-39357038-9064-4697-AAB7-9FB4856E52F2Q47416786-DFFB3F7C-AF5C-4D04-8739-E4ADAACC170BQ48283891-CD925C88-5FD0-461B-A6AD-1B64234C324DQ52149415-93C67A67-F99F-4FE2-A6DF-B05D5F35E7D3Q55628626-AF4F1523-20B5-4348-99AD-910E6016E9D2Q57655341-2912288B-2A0C-47C7-AF5D-AF22E5B0B012
P2860
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Quantification of subtle blood ...... of disease and lesion subtypes
@ast
Quantification of subtle blood ...... of disease and lesion subtypes
@en
Quantification of subtle blood ...... of disease and lesion subtypes
@nl
type
label
Quantification of subtle blood ...... of disease and lesion subtypes
@ast
Quantification of subtle blood ...... of disease and lesion subtypes
@en
Quantification of subtle blood ...... of disease and lesion subtypes
@nl
prefLabel
Quantification of subtle blood ...... of disease and lesion subtypes
@ast
Quantification of subtle blood ...... of disease and lesion subtypes
@en
Quantification of subtle blood ...... of disease and lesion subtypes
@nl
P2093
P2860
P921
P356
P1476
Quantification of subtle blood ...... of disease and lesion subtypes
@en
P2093
P2860
P304
P356
10.1177/1352458507076970
P407
P577
2007-08-01T00:00:00Z